The significance of basket trials lies in their ability to streamline the drug development process. By targeting a specific biomarker found in different cancers, researchers can assess the drug's effectiveness more efficiently. This is particularly crucial as it allows for the identification of potential treatment options for rare cancers that share the same molecular characteristics as more common cancers. The ability to test a single therapy across several cancer types can accelerate the approval process for new drugs, potentially bringing life-saving treatments to patients faster.
